Figure 9
From: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Effects of SLMO2 on proliferation and migration of MDA-MB-231 and A549 cells in vitro. (A) Western blot was used to detect siRNA-SLMO2 infection in MDA-MB-231 and A549 cells. (B) Proliferation assay was used to evaluate cell proliferation in MDA-MB-231 and A549 cells. (C) Clone formation assay was performed to evaluate the growth of MDA-MB-231 and A549 cells. (D) Transwell assays were performed to assess cell migration in MDA-MB-231 and A549 cells.
